| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |